Dr Carey Deyoung Lloyd, MD | |
980 Medical Dr, #2, Brigham City, UT 84302-3094 | |
(435) 734-2433 | |
(435) 734-0059 |
Full Name | Dr Carey Deyoung Lloyd |
---|---|
Gender | Male |
Speciality | Pediatrics |
Location | 980 Medical Dr, Brigham City, Utah |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1164523494 | NPI | - | NPPES |
870631360 | Other | ALTIUS | |
107007623101 | Other | SELECTHEALTH |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | 313975-1205 (Utah) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Carey Deyoung Lloyd, MD Po Box 12173, Ogden, UT 84412-2173 Ph: (435) 734-2433 | Dr Carey Deyoung Lloyd, MD 980 Medical Dr, #2, Brigham City, UT 84302-3094 Ph: (435) 734-2433 |
News Archive
Myriad Genetics has announced the issuance of Patent No. 6,911,466 entitled, "AB42 Lowering Agents". Myriad holds exclusive rights to the patent under a licensing agreement with Mayo Clinic. The patent covers methods of using a broad class of compounds known as selective amyloid beta 42 lowering agents (SALAs) to lower levels of the toxic peptide.
Reproductive hormones that develop during puberty are not responsible for changes in social behavior that occur during adolescence, according to the results of a newly published study by a University at Buffalo researcher.
UCLA researchers have discovered that a combination of drugs, electrical stimulation and regular exercise can enable paralyzed rats to walk and even run again while supporting their full weight on a treadmill.
Researchers from the Molecular Cancer group at the Hospital del Mar Medical Research Institute and doctors from Hospital del Mar, have demonstrated the effectiveness of a drug for treating metastatic bladder cancer in patients who did not respond to the usual treatment.
› Verified 3 days ago